---
category: news
title: "How Artificial Intelligence Can Boost FDA Approvals for Novel Cancer Treatments"
excerpt: "Developing new cancer drugs is a difficult prospect. According to the Pharmaceutical Manufacturers Association, less than 8% of cancer drugs that enter phase 1 clinical trials for U.S. Food and Drug Administration (FDA) approval actually make it to market."
publishedDateTime: 2021-12-16T18:00:00Z
originalUrl: "https://www.nasdaq.com/articles/how-artificial-intelligence-can-boost-fda-approvals-for-novel-cancer-treatments"
webUrl: "https://www.nasdaq.com/articles/how-artificial-intelligence-can-boost-fda-approvals-for-novel-cancer-treatments"
type: article
quality: 43
heat: 43
published: false

provider:
  name: Nasdaq
  domain: nasdaq.com

topics:
  - AI

secured: "cQPQXrHlZnwmrytuzkrwZ/S5JG7mB4lPa0ekcow0x24RkN55VyirE1fYRl/2mfUnFtLowfxt18Xb1oHtmHSvl9cq+AUC7B4zQmJnIOZT0cUTkzu9Y1fGGF8BvZzPQUYsbcvceaj7RweCFvJAxuQ6yt0tcG/w0Jjm0NHGsOXCW2hjm2eTv2neAVOtFhQP5VU/vKHUuYKZd1IV+FoVnPdONUi82tbpfxO1h82HpxSYy6U3rohLkfGhIRp9vsdOKI2aGrBJNAfe9w18I+SNHEdfA7lJj+Fk/0G2MMqayCNg+H9KD0mUxXiKiomdYgGd6ufjyJJocuWgfE8/uOJOu4TlOVicqT/jmItyQ19BmraF4sE=;oex1RAcyyk71GPtCe99RIA=="
---

